These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1534589)

  • 41. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
    Szymański A
    Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096
    [No Abstract]   [Full Text] [Related]  

  • 42. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of pulmonary reaction with skin eruption showing a positive peripheral lymphocyte stimulation test result for ethambutol.
    Hiraoka K; Nagata N; Suzuki K; Kawajiri T; Kurokawa S; Kawamura T; Kido M
    J UOEH; 1998 Jun; 20(2):145-51. PubMed ID: 9644729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fixed drug eruption after taking ethambutol].
    Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
    Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
    Kalankhodzhaev AA; Gamzaeva NF
    Probl Tuberk; 1991; (5):21-2. PubMed ID: 1924235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
    Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
    [No Abstract]   [Full Text] [Related]  

  • 52. Two-three years follow up study of pulmonary tuberculosis treated 6 months with rifampicin-containing regimens.
    Pecak W; Leowski J; Nachman-Bijas J; Mroz-Czajka D; Trzcinski K; Wlazlo Z
    Bull Int Union Tuberc; 1976; 51(1):159-62. PubMed ID: 1030277
    [No Abstract]   [Full Text] [Related]  

  • 53. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
    Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
    N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
    Bobarykin VS
    Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sensitizing effect of rifampicin in combination with isoniazid and streptomycin on microcirculation].
    Sokolova GB; Glik MS
    Probl Tuberk; 1984 Jan; (1):49-52. PubMed ID: 6701171
    [No Abstract]   [Full Text] [Related]  

  • 60. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.